(Mis)use of factor analysis in the study of insulin resistance syndrome

American Journal of Epidemiology

Volumn 159, Issue 11, 2004, Pages 1013-1018

  Lawlor, Debbie A ^a   Ebrahim, Shah ^a   May, Margaret ^a   Davey Smith, George ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Factor analysis; Metabolic syndrome X; Statistical

Indexed keywords

ARTICLE; FACTORIAL ANALYSIS; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY;

FACTOR ANALYSIS, STATISTICAL; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 3142783848     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwh150     Document Type: Note

References (39)

1. Hunter SJ, Garvey WT. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 1998;105:331-45.
2. Cefalu WT. Insulin resistance: cellular and clinical concepts. Exp Biol Med 2001;226:13-26.
3. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998;20:157-72.
4. Stern MP. The insulin resistance syndrome. In: Alberti KGMM, Zimmet P, DeFronzo RA, et al, eds. International textbook of diabetes mellitus. 2nd ed. Chicester, United Kingdom: John Wiley & Sons, Ltd, 1997.
5. Hanley AJ, Karter AJ, Festa A, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642-7.
6. Hanson RL, Imperatore G, Bennett PH, et al. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002;51:3120-7.
7. Arya R, Blangero J, Williams K, et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002;51:841-7.
8. Chen W, Srinivasan SR, Berenson GS. Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study. Am J Hypertens 2001;14:212-17.
9. Shmulewitz D, Auerbach SB, Lehner T, et al. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered 2001;51:8-19.
10. Lindblad U, Langer RD, Wingard DL, et al. Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 2001;153:481-9.
11. Pyorala M, Miettinen H, Halonen P, et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000;20:538-44.
12. Sakkinen PA, Wahl P, Cushman M, et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152:897-907.
13. Chen CH, Lin KC, Tsai ST, et al. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 2000;13:846-53.
14. Snehalatha C, Sivasankari S, Satyavani K, et al. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med 2000;17:152-7.
15. Chen W, Srinivasan SR, Elkasabany A, et al. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol 1999;150:667-74.
16. Lempiainen P, Mykkanen L, Pyorala K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999;100:123-8.
17. Kekalainen P, Sarlund H, Pyorala K, et al. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 1999;22:86-92.
18. Gray RS, Fabsitz RR, Cowan LD, et al. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998;148:869-78.
19. Edwards KL, Burchfiel CM, Sharp DS, et al. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 1998;147:441-7.
20. Leyva F, Godsland IF, Worthington M, et al. Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vasc Biol 1998;18:208-14.
21. Godsland IF, Leyva F, Walton C, et al. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1). J Intern Med 1998;244:33-41.
22. Leyva F, Godsland IF, Ghatei M, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998;18:928-33.
23. Donahue RP, Bean JA, Donahue RD, et al. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 1997;17:2413-17.
24. Meigs JB, D'Agostino RBS, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997;46:1594-600.
25. Wingard D, Von Muhlen D, Barrett-Connor E, et al. Factor analysis of proposed components of the insulin resistance syndrome. (Abstract). Diabetes 1996;45(suppl 2):137A.
26. Edwards KL, Austin MA, Newman B, et al. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994;14:1940-5.
27. Mardia KV, Kent JT, Bibby JM. Factor analysis. In: Mardia KV, Kent JT, Bibby JM, eds. Multivariate analysis. London, United Kingdom: Academic Press, 1979:255-80.
28. Krzanowski WJ. Explaining observed associations: latent-variable models. In: Krzanowski WJ, ed. Principles of multivariate analysis. A user's perspective. Oxford, United Kingdom: Oxford University Press, 1990:474-515.
29. Manly BFJ. Factor analysis. In: Manly BFJ, ed. Multivariate statistical methods. A primer. London, United Kingdom: Chapman & Hall, 1994:93-106.
30. Chatfield C, Collins AJ. Introduction to multivariate analysis. In: Chatfield C, Collins AJ, eds. Introduction to multivariate analysis. London, United Kingdom: Chapman & Hall, 1980: 82-9.
31. Wingard DL, Barrett-Connor E, Criqui MH, et al. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 1983;117:19-26.
32. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-11.
33. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization Department of Noncommunicable Disease Surveillance, 1999.
34. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). JAMA 2001;285:2486-97.
35. Schemper M. Predictive accuracy and explained variation. Stat Med 2003;22:2299-308.
36. Golden SH, Folsom AR, Coresh J, et al. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities Study. Diabetes 2002;51:3069-76.
37. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
38. Lawlor DA, Ebrahim S, Davey Smith G. The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study. Diabet Med (in press).
39. Sterne JA, Davey Smith G. Sifting the evidence - what's wrong with significance tests? BMJ 2001;322:226-31.